|
Name |
10-Methylicosane
|
| Molecular Formula | C21H44 | |
| IUPAC Name* |
10-methylicosane
|
|
| SMILES |
CCCCCCCCCCC(C)CCCCCCCCC
|
|
| InChI |
InChI=1S/C21H44/c1-4-6-8-10-12-14-16-18-20-21(3)19-17-15-13-11-9-7-5-2/h21H,4-20H2,1-3H3
|
|
| InChIKey |
BFAGLVWBOUDHBS-UHFFFAOYSA-N
|
|
| Synonyms |
10-Methylicosane; Eicosane, 10-methyl-; 10-METHYLEICOSANE; 54833-23-7; 10-Methylicosane #; DTXSID60873257
|
|
| CAS | 54833-23-7 | |
| PubChem CID | 41208 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 296.6 | ALogp: | 11.3 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 21 | QED Weighted: | 0.221 |
| Caco-2 Permeability: | -4.859 | MDCK Permeability: | 0.00000598 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.348 |
| 30% Bioavailability (F30%): | 0.999 |
| Blood-Brain-Barrier Penetration (BBB): | 0.053 | Plasma Protein Binding (PPB): | 98.55% |
| Volume Distribution (VD): | 4.063 | Fu: | 1.39% |
| CYP1A2-inhibitor: | 0.124 | CYP1A2-substrate: | 0.167 |
| CYP2C19-inhibitor: | 0.241 | CYP2C19-substrate: | 0.067 |
| CYP2C9-inhibitor: | 0.078 | CYP2C9-substrate: | 0.951 |
| CYP2D6-inhibitor: | 0.146 | CYP2D6-substrate: | 0.03 |
| CYP3A4-inhibitor: | 0.184 | CYP3A4-substrate: | 0.036 |
| Clearance (CL): | 4.739 | Half-life (T1/2): | 0.026 |
| hERG Blockers: | 0.248 | Human Hepatotoxicity (H-HT): | 0.008 |
| Drug-inuced Liver Injury (DILI): | 0.289 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.033 |
| Skin Sensitization: | 0.963 | Carcinogencity: | 0.024 |
| Eye Corrosion: | 0.995 | Eye Irritation: | 0.928 |
| Respiratory Toxicity: | 0.313 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001180 | ![]() |
0.870 | D07ILQ | ![]() |
0.538 | ||
| ENC001143 | ![]() |
0.869 | D00AOJ | ![]() |
0.530 | ||
| ENC000809 | ![]() |
0.762 | D00FGR | ![]() |
0.517 | ||
| ENC000427 | ![]() |
0.758 | D0Z5SM | ![]() |
0.500 | ||
| ENC000400 | ![]() |
0.750 | D0T9TJ | ![]() |
0.463 | ||
| ENC000428 | ![]() |
0.742 | D05ATI | ![]() |
0.427 | ||
| ENC000968 | ![]() |
0.742 | D0O1PH | ![]() |
0.416 | ||
| ENC000379 | ![]() |
0.738 | D0P1RL | ![]() |
0.409 | ||
| ENC000488 | ![]() |
0.727 | D00MLW | ![]() |
0.398 | ||
| ENC000423 | ![]() |
0.717 | D00STJ | ![]() |
0.338 | ||